Riskpilot← Back to searchSign inGet full accessDANONE AS
ASActiveOrg 880346792Drammensveien 123, 0277 OsloWholesale of other food · NACE 4638Est. 199827 employeeswww.nutricia.no
Revenue 2024
NOK 413,2M
+12% vs 2023
EBITDA margin
0.8%
+2148% vs 2023
Equity ratio
70.6%
Financial strength
Net profit 2024
NOK -60,3M
-36% vs 2023
| Revenue | NOK 413,2M | +12% |
| EBITDA | NOK 3,1M | +2148% |
| Net profit | NOK -60,3M | -36% |
| Total assets | NOK 320,7M | -15% |
| Equity | NOK 226,4M | -21% |
| Employees | 27 | — |
Legal name
DANONE AS
Org number
880346792
Legal form
Aksjeselskap
NACE code
4638 · Wholesale of other food
Founded
25. november 1998
Share capital
NOK 110 000
Employees
27 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder eller ett styremedlem eller daglig leder hver for seg.
Company purpose
Salg og distribusjon av helsefremmende produkter og utstyr, herunder ernæringsprodukter til spesielle medisinske og kliniske formål. Videre skal selskapet bedrive grossistvirksomhet for meieriprodukter, samt enhver tilhørende drift til det overnevnte.
Address
Drammensveien 123, 0277 Oslo
Website
www.nutricia.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 102 388 | 116 044 | 129 111 | 139 829 | 154 233 | 154 595 | 166 165 | 174 404 | 190 256 | 207 693 | 224 803 | 230 616 | 239 641 | 231 459 | 265 861 | 370 331 | 413 188 |
| Staff expenses | −13 250 | −15 680 | −17 720 | −18 824 | −21 605 | −14 087 | −21 738 | −21 074 | −15 839 | −19 894 | −20 579 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 15 657 | 3 308 | 8 262 | 6 357 | 10 473 | 7 637 | 660 | −17 | 5 890 | 7 040 | 6 440 | 7 052 | 8 381 | 5 279 | 19 030 | −153 | 3 142 |
| Depreciation & amort. | −827 | −832 | −823 | −252 | −166 | −138 | −96 | −89 | −71 | −53 | −48 | −120 | −104 | −72 | −7 339 | −43 867 | −81 593 |
| EBIT | 14 830 | 2 476 | 7 440 | 6 105 | 10 307 | 7 499 | 564 | −107 | 5 820 | 6 987 | 6 392 | 6 933 | 8 278 | 5 208 | 11 691 | −44 020 | −78 451 |
| Net financials | 934 | −699 | −201 | −1 168 | −1 545 | −1 991 | −176 | 993 | −1 700 | −1 728 | −1 642 | −2 245 | −2 232 | 98 | −1 263 | −12 567 | 1 390 |
| Profit before tax | 15 764 | 1 777 | 7 239 | 4 937 | 8 762 | 5 508 | 389 | 886 | 4 120 | 5 259 | 4 749 | 4 687 | 6 046 | 5 306 | 10 428 | −56 587 | −77 061 |
| Tax | −0 | 906 | 2 410 | 1 476 | 2 561 | 2 659 | 170 | 381 | 1 123 | 1 426 | 1 160 | 1 073 | 1 390 | −0 | −0 | −0 | −0 |
| Net profit | 15 764 | 871 | 4 828 | 3 461 | 6 201 | 2 850 | 219 | 505 | 2 996 | 3 833 | 3 589 | 3 614 | 4 656 | 4 103 | 7 559 | −44 229 | −60 266 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 47 021 | 37 580 | 36 154 | 37 243 | 48 365 | 40 559 | 52 197 | 52 344 | 53 569 | 59 108 | 64 519 | 51 724 | 76 304 | 69 370 | 381 020 | 376 501 | 320 716 |
| Equity | 9 186 | 5 223 | 4 168 | 4 428 | 4 910 | 9 142 | 8 682 | 8 806 | 9 000 | 10 033 | 10 122 | 10 237 | 10 237 | 14 340 | 21 899 | 286 670 | 226 403 |
| Long-term debt | 0 | 9 175 | 0 | −4 286 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 741 | 6 785 | 269 | 0 |
| Short-term debt | 37 509 | 21 651 | 29 119 | 28 529 | 36 283 | 31 417 | 43 516 | 43 538 | 44 569 | 49 075 | 54 396 | 41 487 | 66 067 | 53 288 | 352 336 | 89 562 | 94 312 |
| Total debt | 37 509 | 30 826 | 29 119 | 28 529 | 36 283 | 31 417 | 43 516 | 43 538 | 44 569 | 49 075 | 54 396 | 41 487 | 66 067 | 55 030 | 359 121 | 89 831 | 94 312 |
EBITDA margin
0.8%
This company
15.8%
Market median
-95% vs market
20082024
Equity ratio
70.6%
This company
38.2%
Market median
+85% vs market
20082024
Return on equity
-26.6%
This company
18.4%
Market median
-245% vs market
20082024
Net profit margin
-14.6%
This company
8.1%
Market median
-280% vs market
20082024
Asset turnover
1.29×
This company
1.12×
Market median
+15% vs market
20082024
Debt / equity
0.42×
This company
0.62×
Market median
+32% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ID Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
MT Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
MM Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2026 | — | — | |
| Chairman | 2026 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Nutricia International Bv | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DANONE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Isaac Diaz Marin | Chief Executive Officer | 0 companies |
| Miki-Pekka Tapio Aho | Chief Executive Officer | 0 companies |
| Mette Mundt Drakenberg | Chief Executive Officer | 0 companies |
| Maxime Komardine | Board of Directors | 0 companies |
| Ignasi Argente Arbos | Chairman | 0 companies |
| Stephanie Enzinger | Board of Directors | 0 companies |
| Richard Luiz Trechman | Chairman | 0 companies |
| Samuel James Wolfenden | Board of Directors | 0 companies |
| Manu Claessens | Chairman | 0 companies |
| Blagovesta Dimitrova Karemova | Board of Directors | 0 companies |
| Hilde Ragna Åsheim | Board of Directors | 0 companies |
| Johannes Van Der Wulp | Chairman | 0 companies |